Warfarin

Known as: 3-Alpha-phenyl-beta-acetylethyl-4-hydroxycoumarin, 3-(.alpha.-Phenyl-.beta.-acetylethyl)-4-hydroxycoumarin, 2H-1-Benzopyran-2-one, 4-hydroxy-3-(3-oxo-1-phenylbutyl)- 
A synthetic anticoagulant. Warfarin inhibits the regeneration of vitamin K1 epoxide and so the synthesis of vitamin K dependent clotting factors… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1949-2018
05001000150019492017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
BACKGROUND Cluster headache (CH), the most common trigeminal autonomic cephalalgia, is an extremely debilitating primary headache… (More)
Is this relevant?
Highly Cited
2014
Highly Cited
2014
BACKGROUND Four new oral anticoagulants compare favourably with warfarin for stroke prevention in patients with atrial… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2013
Highly Cited
2013
BACKGROUND Patients with atrial fibrillation who are vitamin K antagonist (VKA)-naive may have a higher risk of thrombosis and/or… (More)
Is this relevant?
Highly Cited
2013
Highly Cited
2013
BACKGROUND Edoxaban is a direct oral factor Xa inhibitor with proven antithrombotic effects. The long-term efficacy and safety of… (More)
  • table 1
  • figure 1
Is this relevant?
Highly Cited
2011
Highly Cited
2011
BACKGROUND The use of warfarin reduces the rate of ischemic stroke in patients with atrial fibrillation but requires frequent… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2009
Highly Cited
2009
BACKGROUND Warfarin reduces the risk of stroke in patients with atrial fibrillation but increases the risk of hemorrhage and is… (More)
  • table 1
Is this relevant?
Highly Cited
2009
Highly Cited
2009
From the Department of Medicine, McMaster University and Henderson Research Centre, Hamilton, ON, Canada (S. Schulman, C.K.); the… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND Anticoagulants are more effective than antiplatelet agents at reducing stroke risk in patients with atrial… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND The management of warfarin therapy is complicated by a wide variation among patients in drug response. Variants in the… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND Atherosclerotic intracranial arterial stenosis is an important cause of stroke. Warfarin is commonly used in… (More)
  • figure 1
  • table 1
  • table 1
  • table 2
  • figure 2
Is this relevant?